KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 95 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,091,079 | +73.6% | 62,814 | +40.7% | 0.00% | – |
| Q2 2023 | $628,573 | +13.8% | 44,643 | -13.0% | 0.00% | – |
| Q1 2023 | $552,149 | -35.5% | 51,315 | -10.1% | 0.00% | – |
| Q4 2022 | $855,433 | +7028.6% | 57,105 | +4768.3% | 0.00% | – |
| Q1 2022 | $12,000 | -98.7% | 1,173 | -98.5% | 0.00% | – |
| Q4 2021 | $900,000 | -4.5% | 76,475 | -7.6% | 0.00% | – |
| Q3 2021 | $942,000 | +237.6% | 82,737 | +313.3% | 0.00% | – |
| Q2 2021 | $279,000 | -57.7% | 20,019 | -43.8% | 0.00% | – |
| Q1 2021 | $660,000 | +2650.0% | 35,643 | +2507.4% | 0.00% | – |
| Q4 2020 | $24,000 | -36.8% | 1,367 | -45.5% | 0.00% | – |
| Q3 2020 | $38,000 | -86.0% | 2,510 | -76.4% | 0.00% | – |
| Q2 2020 | $271,000 | +142.0% | 10,651 | +47.7% | 0.00% | – |
| Q1 2020 | $112,000 | -46.7% | 7,210 | -62.0% | 0.00% | – |
| Q4 2019 | $210,000 | +162.5% | 18,968 | +102.6% | 0.00% | – |
| Q3 2019 | $80,000 | +247.8% | 9,364 | +439.7% | 0.00% | – |
| Q2 2019 | $23,000 | -41.0% | 1,735 | +13.4% | 0.00% | – |
| Q3 2018 | $39,000 | – | 1,530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |